BVS - Bioventus Non-GAAP EPS of -$0.06 misses by $0.11 revenue of $125.83M misses by $6.87M
2023-03-31 08:58:20 ET
- Bioventus press release ( NASDAQ: BVS ): Q4 Non-GAAP EPS of -$0.06 misses by $0.11 .
- Revenue of $125.83M (-3.5% Y/Y) misses by $6.87M .
- Non-GAAP gross profit was $89.6 million, or 71.2% of net sales, compared to $99.6 million, or 76.3% of net sales, for the fourth quarter of 2021, a decrease of $10.0 million year-over-year.
- Adjusted EBITDA was $15.2 million, compared to $28.5 million for the fourth quarter of 2021, a decrease of $13.3 million year-over-year.
For further details see:
Bioventus Non-GAAP EPS of -$0.06 misses by $0.11, revenue of $125.83M misses by $6.87M